|
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC), in patients (pt) treated with pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): First results of the SOGUG SPAZO study. |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - GE Healthcare |
Speakers' Bureau - GlaxoSmithKline |
| |
|
Consulting or Advisory Role - GlaxoSmithKline |
Speakers' Bureau - GlaxoSmithKline |
| |
|
Consulting or Advisory Role - GlaxoSmithKline |
Speakers' Bureau - GlaxoSmithKline |
| |
|
Consulting or Advisory Role - GlaxoSmithKline |
| |
|
Consulting or Advisory Role - GlaxoSmithKline |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - GlaxoSmithKline |
| |
Constanza Maximiano Alonso |
Consulting or Advisory Role - GlaxoSmithKline |
| |
|
Consulting or Advisory Role - GlaxoSmithKline |
| |
José Carlos Villa Guzman |
Consulting or Advisory Role - GlaxoSmithKline |
| |
|
Consulting or Advisory Role - GlaxoSmithKline |
| |
|
Consulting or Advisory Role - GlaxoSmithKline |
| |
|
Consulting or Advisory Role - GlaxoSmithKline |
| |
|
Consulting or Advisory Role - GlaxoSmithKline |
| |
|
Consulting or Advisory Role - GlaxoSmithKline |
| |
Julio Jose Lambea- Sorrosal |
Consulting or Advisory Role - GlaxoSmithKline |
| |
Aranzazu Gonzalez del Alba |
Consulting or Advisory Role - Astellas Pharma; Bayer; GlaxoSmithKline; Sanofi |
Speakers' Bureau - Astellas Pharma; Bayer; GlaxoSmithKline; Janssen-Cilag |
| |
Edelmira Velez De Mendizabal |
Consulting or Advisory Role - GlaxoSmithKline |
| |
Jose-Luis Gonzalez-Larriba |
Consulting or Advisory Role - GlaxoSmithKline |